| Literature DB >> 27036007 |
Peng Liu1, Yilin Ping2, Meng Ma3, Demao Zhang2, Connie Liu3, Samir Zaidi4, Song Gao5, Yaoting Ji6, Feng Lou2, Fanyuan Yu2, Ping Lu7, Agnes Stachnik7, Mingru Bai2, Chengguo Wei3, Liaoran Zhang2, Ke Wang2, Rong Chen3, Maria I New8, David W Rowe9, Tony Yuen7, Li Sun7, Mone Zaidi10.
Abstract
Notch controls skeletogenesis, but its role in the remodeling of adult bone remains conflicting. In mature mice, the skeleton can become osteopenic or osteosclerotic depending on the time point at which Notch is activated or inactivated. Using adult EGFP reporter mice, we find that Notch expression is localized to osteocytes embedded within bone matrix. Conditional activation of Notch signaling in osteocytes triggers profound bone formation, mainly due to increased mineralization, which rescues both age-associated and ovariectomy-induced bone loss and promotes bone healing following osteotomy. In parallel, mice rendered haploinsufficient in γ-secretase presenilin-1 (Psen1), which inhibits downstream Notch activation, display almost-absent terminal osteoblast differentiation. Consistent with this finding, pharmacologic or genetic disruption of Notch or its ligand Jagged1 inhibits mineralization. We suggest that stimulation of Notch signaling in osteocytes initiates a profound, therapeutically relevant, anabolic response.Entities:
Keywords: aging; osteoporosis; skeletal mineralization; therapeutic target
Mesh:
Substances:
Year: 2016 PMID: 27036007 PMCID: PMC4839423 DOI: 10.1073/pnas.1603399113
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205